Role of nuclear grading in stage I renal cell carcinoma

Linda K. Green, Alberto G. Ayala, Jae Y. Ro, David A. Swanson, David J. Grignon, Geoffrey G. Giacco, Vincent E. Guinee

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Through a retrospective histologic analysis of 55 cases of Stage I renal cell carcinoma, we evaluated the usefulness of the nuclear grading system (Fuhrman, Lasky, Limas) in identifying those tumors that will eventually metastasize and kill the patient. The difference in five-year survival rates between patients with combined nuclear grade 1-3 tumors (n = 50, 91%) and grade 4 tumors (n = 5, 9%) was significant (P < 0.0046). Other predictors of death due to renal cell carcinoma included: tumor size greater than 8 cm (P < 0.001) and mitoses greater than one per 10 high-power field (P < 0.01). Within Stage I tumors, therefore, nuclear grade is an important morphologic variable for predicting long-term survival. Identification of nuclear grade 4 neoplasms may become prognostically indispensable to determine the metastatic potential of early-stage tumors and thereby to institute appropriate systemic therapy.

Original languageEnglish (US)
Pages (from-to)310-315
Number of pages6
JournalUrology
Volume34
Issue number5
DOIs
StatePublished - Nov 1989

Fingerprint

Renal Cell Carcinoma
Neoplasms
Mitosis
Survival Rate
Survival

ASJC Scopus subject areas

  • Urology

Cite this

Green, L. K., Ayala, A. G., Ro, J. Y., Swanson, D. A., Grignon, D. J., Giacco, G. G., & Guinee, V. E. (1989). Role of nuclear grading in stage I renal cell carcinoma. Urology, 34(5), 310-315. https://doi.org/10.1016/0090-4295(89)90333-6

Role of nuclear grading in stage I renal cell carcinoma. / Green, Linda K.; Ayala, Alberto G.; Ro, Jae Y.; Swanson, David A.; Grignon, David J.; Giacco, Geoffrey G.; Guinee, Vincent E.

In: Urology, Vol. 34, No. 5, 11.1989, p. 310-315.

Research output: Contribution to journalArticle

Green, LK, Ayala, AG, Ro, JY, Swanson, DA, Grignon, DJ, Giacco, GG & Guinee, VE 1989, 'Role of nuclear grading in stage I renal cell carcinoma', Urology, vol. 34, no. 5, pp. 310-315. https://doi.org/10.1016/0090-4295(89)90333-6
Green LK, Ayala AG, Ro JY, Swanson DA, Grignon DJ, Giacco GG et al. Role of nuclear grading in stage I renal cell carcinoma. Urology. 1989 Nov;34(5):310-315. https://doi.org/10.1016/0090-4295(89)90333-6
Green, Linda K. ; Ayala, Alberto G. ; Ro, Jae Y. ; Swanson, David A. ; Grignon, David J. ; Giacco, Geoffrey G. ; Guinee, Vincent E. / Role of nuclear grading in stage I renal cell carcinoma. In: Urology. 1989 ; Vol. 34, No. 5. pp. 310-315.
@article{77427118448b4e4f9114648f5679b9ee,
title = "Role of nuclear grading in stage I renal cell carcinoma",
abstract = "Through a retrospective histologic analysis of 55 cases of Stage I renal cell carcinoma, we evaluated the usefulness of the nuclear grading system (Fuhrman, Lasky, Limas) in identifying those tumors that will eventually metastasize and kill the patient. The difference in five-year survival rates between patients with combined nuclear grade 1-3 tumors (n = 50, 91{\%}) and grade 4 tumors (n = 5, 9{\%}) was significant (P < 0.0046). Other predictors of death due to renal cell carcinoma included: tumor size greater than 8 cm (P < 0.001) and mitoses greater than one per 10 high-power field (P < 0.01). Within Stage I tumors, therefore, nuclear grade is an important morphologic variable for predicting long-term survival. Identification of nuclear grade 4 neoplasms may become prognostically indispensable to determine the metastatic potential of early-stage tumors and thereby to institute appropriate systemic therapy.",
author = "Green, {Linda K.} and Ayala, {Alberto G.} and Ro, {Jae Y.} and Swanson, {David A.} and Grignon, {David J.} and Giacco, {Geoffrey G.} and Guinee, {Vincent E.}",
year = "1989",
month = "11",
doi = "10.1016/0090-4295(89)90333-6",
language = "English (US)",
volume = "34",
pages = "310--315",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Role of nuclear grading in stage I renal cell carcinoma

AU - Green, Linda K.

AU - Ayala, Alberto G.

AU - Ro, Jae Y.

AU - Swanson, David A.

AU - Grignon, David J.

AU - Giacco, Geoffrey G.

AU - Guinee, Vincent E.

PY - 1989/11

Y1 - 1989/11

N2 - Through a retrospective histologic analysis of 55 cases of Stage I renal cell carcinoma, we evaluated the usefulness of the nuclear grading system (Fuhrman, Lasky, Limas) in identifying those tumors that will eventually metastasize and kill the patient. The difference in five-year survival rates between patients with combined nuclear grade 1-3 tumors (n = 50, 91%) and grade 4 tumors (n = 5, 9%) was significant (P < 0.0046). Other predictors of death due to renal cell carcinoma included: tumor size greater than 8 cm (P < 0.001) and mitoses greater than one per 10 high-power field (P < 0.01). Within Stage I tumors, therefore, nuclear grade is an important morphologic variable for predicting long-term survival. Identification of nuclear grade 4 neoplasms may become prognostically indispensable to determine the metastatic potential of early-stage tumors and thereby to institute appropriate systemic therapy.

AB - Through a retrospective histologic analysis of 55 cases of Stage I renal cell carcinoma, we evaluated the usefulness of the nuclear grading system (Fuhrman, Lasky, Limas) in identifying those tumors that will eventually metastasize and kill the patient. The difference in five-year survival rates between patients with combined nuclear grade 1-3 tumors (n = 50, 91%) and grade 4 tumors (n = 5, 9%) was significant (P < 0.0046). Other predictors of death due to renal cell carcinoma included: tumor size greater than 8 cm (P < 0.001) and mitoses greater than one per 10 high-power field (P < 0.01). Within Stage I tumors, therefore, nuclear grade is an important morphologic variable for predicting long-term survival. Identification of nuclear grade 4 neoplasms may become prognostically indispensable to determine the metastatic potential of early-stage tumors and thereby to institute appropriate systemic therapy.

UR - http://www.scopus.com/inward/record.url?scp=0024429438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024429438&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(89)90333-6

DO - 10.1016/0090-4295(89)90333-6

M3 - Article

C2 - 2815458

AN - SCOPUS:0024429438

VL - 34

SP - 310

EP - 315

JO - Urology

JF - Urology

SN - 0090-4295

IS - 5

ER -